Skip to main content

Table 3 Partial end-point components of the phenotypic prototypes from the clustering of the acetaminophen-treated samples.

From: Simultaneous clustering of gene expression data with clinical chemistry and pathological evaluations reveals phenotypic prototypes

  Cluster
Features 1 2 3
Cong_Sinusoid Moderate None Minimal
Necr_Cent Moderate None Mild
Infl_Cent None None Minimal/Mild*
Hypert_Hepa Minimal None None
Regen_Hepa None None Minimal
Dege_Hepa* None None Minimal
ALB (g/dL) 5.16 5.03 4.78
ALP (IU/L) 413.22 323.43 368.78
ALT (IU/L) 9649.40 118.48 1676.10
AST (IU/L) 20304.00 171.80 2820.20
Creat (mg/dL) 0.70 0.70 0.70
BUN (mg/dL) 23.56 15.56 18.11
CHOLE (mg/dL) 59.78 86.54 85.44
TBA (umol/L) 61.67 7.61 43.56
SDH (IU/L) 2.89 32.41 398.89
TP (g/dL) 7.53 7.52 7.19
* Observed in the left medial lobe